Organogenesis Holdings (ORGO) Total Current Liabilities (2015 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Total Current Liabilities of $76.0 million for Q1 2026, up 16.86% year-over-year from $65.1 million in Q1 2025, and down 24.07% quarter-over-quarter from $100.1 million in Q4 2025.
Organogenesis Holdings (ORGO) Total Current Liabilities (2015 - 2026) Analysis & Trends
Organogenesis Holdings' Total Current Liabilities history runs 12 years deep, the most recent figure standing at $76.0 million for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 16.86% year-over-year to $76.0 million; the TTM figure through Mar 2026 stood at $76.0 million (up 16.86% YoY), while the FY2025 annual figure was $100.1 million, up 29.23% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $76.0 million, down from $100.1 million in the prior quarter.
- The five-year high for Total Current Liabilities was $100.1 million in Q4 2025, with the low at $65.1 million in Q1 2025.
- The 5-year median for Total Current Liabilities is $78.5 million (2022), against an average of $80.2 million.
- Peak annual rise in Total Current Liabilities reached 29.23% in 2025, while the deepest fall reached 23.2% in 2025.
- Organogenesis Holdings' Total Current Liabilities stood at $75.0 million in 2022, then climbed by 7.31% to $80.5 million in 2023, then slipped by 3.77% to $77.5 million in 2024, then gained by 29.23% to $100.1 million in 2025, then declined by 24.07% to $76.0 million in 2026.
- Business Quant data shows ORGO's Total Current Liabilities at $76.0 million in Q1 2026, $100.1 million in Q4 2025, and $90.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.79 Bn |
| 10 | Organogenesis Holdings | 238.69 Mn | 191.85 Mn | 20.08 Mn | 56.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 56.96 Mn |
| Mar 31, 2026 | 76.02 Mn |
| Dec 31, 2025 | 100.12 Mn |
| Sep 30, 2025 | 90.32 Mn |
| Jun 30, 2025 | 65.84 Mn |
| Mar 31, 2025 | 65.05 Mn |
| Dec 31, 2024 | 77.48 Mn |
| Sep 30, 2024 | 77.28 Mn |
| Jun 30, 2024 | 85.73 Mn |
| Mar 31, 2024 | 82.80 Mn |
| Dec 31, 2023 | 80.51 Mn |
| Sep 30, 2023 | 81.48 Mn |
| Jun 30, 2023 | 73.46 Mn |
| Mar 31, 2023 | 76.08 Mn |
| Dec 31, 2022 | 75.02 Mn |
| Sep 30, 2022 | 89.27 Mn |
| Jun 30, 2022 | 88.23 Mn |
| Mar 31, 2022 | 78.49 Mn |
| Dec 31, 2021 | 82.71 Mn |
| Sep 30, 2021 | 81.00 Mn |